...
SOLVLARGE

Solventum Corporation

HealthcareMedical - Care Facilities
$74.20
$0.03(-3.56%)
52W$60.70
$88.20
FinancialsValuationvs HCSG
Updated Feb 28, 12:00 AM
RSI51
RS Rating43/99
Beta0.97
Volatility32%
F-Score6/9
Mkt Cap$12.9B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Solventum Corporation shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is weak (RS Rating: 43), showing significant lag compared to the market leaders. Earnings growth of 106% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
43
out of 99
Lagging
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.97
vs S&P 500
MARKET
52W Position
49%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$78.70
50 SMA > 100 SMA$77.39
100 SMA > 150 SMA$75.86
150 SMA > 200 SMA$75.45

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$75.98-2.34%BELOW
50 SMA$78.70-5.72%BELOW
100 SMA$77.39-4.12%BELOW
150 SMA$75.86-2.19%BELOW
200 SMA$75.45-1.66%BELOW

Price Performance

1D-3.6%
1W+2.1%
1M-3.1%
3M-13.0%
6M+2.1%
YTD-6.1%
1Y-7.0%
3Y-2.5%
52-Week Trading Range49% from low
$74.20
52W Low$60.70
52W High$88.20

Technical Indicators

RSI (14)NEUTRAL
50.9
305070
VCP ScoreCOOL
5/10
Base depth: 20.0%

Risk Profile

Beta
0.97
52W Vol
32%
ATR
$2.56
Max DD (1Y)
-21%

Volume Analysis

Today
74
50D Avg
788.4K
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q1'25-43%
$0.78
Q2'25—
$0.51
Q3'25+931%
$7.22
Q4'25+106%
$0.37
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:—
5 Years:—
3 Years:+0.79%
TTM:+0.86%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:+4.46%
TTM:+221.74%

Stock Price CAGR

10 Years:-0.75%
5 Years:-1.49%
3 Years:-2.48%
1 Year:-6.96%

Return on Equity

10Y Avg:16.1%
5Y Avg:16.1%
3Y Avg:19.0%
Last Year:30.8%

Key Metrics

Market Cap$12.9B
Gross Margin53.5%
Net Margin18.7%
Piotroski F-Score6/9

More SOLV Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

SOLV vs HCSGHCSGAMNCCRNCCEL

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 43 meansSOLV outperformed 43% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.97 means 3% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 6/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 5/10 with COOL status.

Frequently Asked Questions

Is SOLV in an uptrend right now?

SOLV has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is SOLV overbought or oversold?

SOLV's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.

Is SOLV outperforming the market?

SOLV has a Relative Strength (RS) Rating of 43 out of 99. SOLV is currently lagging the broader market.

Where is SOLV in its 52-week range?

SOLV is trading at $74.20, which is 84% of its 52-week high ($88.20) and 49% above its 52-week low ($60.70).

How volatile is SOLV?

SOLV has a Beta of 0.97 and 52-week volatility of 32%. It's less volatile than the S&P 500 - generally more stable.